These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16862288)
1. Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery. Magalhães AP; Gus M; Silva LB; Schaan BD Braz J Med Biol Res; 2006 Jul; 39(7):969-78. PubMed ID: 16862288 [TBL] [Abstract][Full Text] [Related]
2. Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery. Choi YS; Kwak YL; Kim JC; Chun DH; Hong SW; Shim JK Anaesthesia; 2009 Aug; 64(8):871-7. PubMed ID: 19604191 [TBL] [Abstract][Full Text] [Related]
3. Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial. Zhang JQ; Yang QY; Xue FS; Zhang W; Yang GZ; Liao X; Meng FM Medicine (Baltimore); 2018 Sep; 97(36):e12100. PubMed ID: 30200092 [TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome? Thrush DN; Austin D; Burdash N Chest; 1995 Dec; 108(6):1541-5. PubMed ID: 7497757 [TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Holland FW; Brown PS; Weintraub BD; Clark RE Ann Thorac Surg; 1991 Jul; 52(1):46-50. PubMed ID: 2069461 [TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine therapy in open-heart surgery: from hope to disappointment. Teiger E; Menasché P; Mansier P; Chevalier B; Lajeunie E; Bloch G; Piwnica A Eur Heart J; 1993 May; 14(5):629-33. PubMed ID: 8389710 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. Bennett-Guerrero E; Jimenez JL; White WD; D'Amico EB; Baldwin BI; Schwinn DA JAMA; 1996 Mar; 275(9):687-92. PubMed ID: 8594265 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of oral tri-iodothyronine in patients undergoing valvular cardiac surgery. Lee JY; Park HY; Kim BS; Kwak YL Korean J Anesthesiol; 2009 May; 56(5):535-542. PubMed ID: 30625785 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and pattern of sick euthyroid syndrome in acute and chronic non-thyroidal illness--its relationship with severity and outcome of the disorder. Zargar AH; Ganie MA; Masoodi SR; Laway BA; Bashir MI; Wani AI; Salahuddin M J Assoc Physicians India; 2004 Jan; 52():27-31. PubMed ID: 15633715 [TBL] [Abstract][Full Text] [Related]
15. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. Chuang CP; Jong YS; Wu CY; Lo HM Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111 [TBL] [Abstract][Full Text] [Related]
16. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Goarin JP; Cohen S; Riou B; Jacquens Y; Guesde R; Le Bret F; Aurengo A; Coriat P Anesth Analg; 1996 Jul; 83(1):41-7. PubMed ID: 8659763 [TBL] [Abstract][Full Text] [Related]